Shareholder class action lawsuit filed against SeaStar Medical alleging misstatements about FDA approval and restatement

SeaStar Medical Holding Corp

Plaintiff Forrest A K Wells filed putative class action on July 5, 2024 in Colorado federal court.
Alleges material misstatements/omissions regarding FDA approval of product candidates and business operations.
Claims under Section 10(b) of Exchange Act against Company, CEO, and former CFO; also Section 20(a).
Seeks compensatory and other damages; Company intends to vigorously defend the action.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.